Medicare claims analyses offer insight into how proposed policy changes would affect out-of-pocket prescription costs for Part D beneficiaries requiring specialty drugs.
Vrushabh P. Ladage, BS
Advertisement
Articles by Vrushabh P. Ladage, BS
The authors review published evidence regarding associations between high cost sharing for specialty pharmaceuticals indicated for rheumatoid arthritis, multiple sclerosis, and cancer, and their utilization.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
2
Patient Portal Messages Outpace Office Visits
3
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
4
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
5